HOTEL INFO: Please call us to assist with room reservation
Westin Hilton Head Island Resort and Spa
Dr. Sandra Benavides, Pharm D, FCCP, FPPAG
Philadelphia College of Osteopathic Medicine, School of Pharmacy
Dr Benavides received her Pharm D from the University of California, San Francisco. She completed a general practice residency at the University of California, San Diego Medical Center and a Pediatric Pharmacotherapy Fellowship at Ohio State University. She is currently an Assistant Dean for Assessment and Quality Programs at PCOM School of Pharmacy in Suwanee, Georgia. She serves as the lead editor in the Pediatric Pharmacotherapy and the Pediatric Pharmacotherapy Self Assessment books. Dr Benavides has practiced in pediatrics in acute care, ambulatory, and community practice. She is dedicated to the education of pharmacists to work towards improved care for pediatric patients.
Friday October 18, 2024
Saturday October 19, 2024
Speaker: Joshua Caballero, PharmD, BCPP, FCCP
University of Georgia, College of Pharmacy
Dr. Joshua Caballero completed a BA in Psychology from the University of Florida and received his PharmD from the University of Tennessee Health Science Center. Afterwards, he completed a psychiatric residency at the University of Texas Health Science Center at San Antonio and a pharmacotherapy fellowship at The Ohio State University. Dr. Caballero is board certified in psychiatric pharmacy and has worked extensively with underserved populations including establishing pharmacy outpatient clinical services. Dr. Caballero’s research interests include the effects of psychotropic agents in various populations and their impact on cognition, health literacy in HIV, and pharmacy education. He has presented many times at national conferences, secured extramural funding, and published in academic peer-reviewed journals. He has been the recipient of several teaching and advising awards at the University and national level.
Sunday October 20, 2024
1. Describe traditional pharmacologic and nonpharmacologic treatment options and expectations for cognitive disorders.
2. Summarize newer treatment options for cognitive disorders (e.g., Alzheimer’s disease).
3. Recognize preferred treatment options for managing comorbid psychiatric complications in patients with cognitive disorders.
4. Describe how to effectively counsel caregivers and patients (when applicable) regarding treatment options for cognitive disorders.
5. Discuss appropriate ways to provide information on support services for caregivers to individuals with cognitive disorders.